CytoMed Therapeutics receives Nasdaq minimum bid shortfall notice

CytoMed Therapeutics Limited received a Nasdaq notice that its shares closed below the $1.00 minimum bid for 30 straight business days. The company has 180 days, until Apr 5, 2027, to regain compliance, with a potential additional 180 days subject to conditions.Material DetailsContext by AI Analyst…